RUBICON ORGANICS COMMENCES EU-GMP CERTIFICATION PROCESS

Download PDF

VANCOUVER, BRITISH COLUMBIA – March 12, 2019 — Rubicon Organics Inc. (CSE:ROMJ) (OTCQX:ROMJF) (“Rubicon Organics” or the “Company”) a super-premium, organic cannabis producer with operations in Canada, Washington and California, is proud to announce that its 125,000 sq. ft. licensed facility in Delta, B.C. (the “BC Facility”) has commenced preparation for its European Union – Good Manufacturing Practices (“EU-GMP”) certification.  The EU-GMP certification is given to companies who demonstrate a high degree of precision and consistency in their manufacturing procedures, and is a requirement for the import of medical cannabis products into the European market.  

Working with Q&C, GMP consultants who have extensive experience across cannabis and international pharmaceutical industries, the BC Facility recently completed a trial audit as the first step in ensuring the correct controls and compliance are in place for European sales.

“We expect access to EU-GMP certified organic cannabis will be a game changer for medical markets both locally and internationally,” said Jesse McConnell, Co-Founder and CEO of Rubicon Organics.  “With Q&C supporting our process, we look forward to providing access to our extensive genetics and top-tier terpene profiles around the world.”

Achieving the required EU-GMP certification will further enhance Rubicon Organics’ reputation as a leading organic producer providing global access to pharmaceutical grade organic cannabis.

Rubicon Organics anticipates the first harvest at its BC Facility in Q2 2019.

ABOUT RUBICON ORGANICS INC.

Rubicon Organics Inc. (“Rubicon Organics” or the “Company) (CSE:ROMJ) (OTCQX:ROMJF) is a Licensed Producer focused on building super-premium organic cannabis brands* with operations in Canada, Washington and California. Rubicon Organics’ flagship Canadian facility is a 125,000 sq. ft. state-of-the-art hybrid greenhouse with industry leading LED lighting and is located on a 20-acre property in Delta, British Columbia. The Company’s Washington facility is a newly constructed, 40,000 sq. ft. hybrid greenhouse and extraction facility. Rubicon Organics has commenced production in both facilities with a combined Phase I capacity of 15,500 kg per year, including 4,500 kg leased to a Washington State licensed operator applying Rubicon Organics’ proprietary organic cultivation methods*. The Company also owns two award-winning U.S. cannabis brands: 1964 Supply Co.TM in California and Doctor & Crook Co.TM in Washington.

* Organic certification pending from FVOPA

CONTACT INFORMATION

Corporate:

Margaret Brodie

Chief Financial Officer

Phone: +1 (437) 929-1964

Email: ir@rubiconorganics.com

Media:

Megan Cunningham

Gear Communications

Phone: +1 (781) 727-8462

Email: mcunningham@gearcommunications.com

Cautionary Statement Regarding Forward Looking Information

This press release contains forward-looking information within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, statements regarding Rubicon Organics’ plan to cultivate, timing and estimates of production for its facilities, are “forward-looking statements”.  Forward-looking information can be identified by the use of words such as “plans” or “is expected”, or variations of such words and phrases or statements that certain actions, events or results are “to begin”, “ramping up to”, “imminent”, “set to” or “will” be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward looking statements.

The forward looking information in this press release is based upon certain assumptions that management considers reasonable in the circumstances, including that its capital needs will be as currently projected, that Rubicon Organics will be able to successfully obtain all necessary permits and approvals to conduct its business as currently proposed to be conducted, that Rubicon Organics will not be prosecuted in the U.S. for its involvement in the cannabis industry.

Risks and uncertainties associated with the forward looking information in this press release include, among others, dependence on obtaining and maintaining regulatory approvals, including acquiring and renewing state, local or other licenses and any inability to obtain all necessary governmental approvals licenses and permits to complete construction of its proposed facilities in a timely manner; engaging in activities which currently are illegal under U.S. federal law and the uncertainty of existing protection from U.S. federal or other prosecution; regulatory or political change such as changes in applicable laws and regulations, including U.S. state-law legalization, particularly in California, due to inconsistent public opinion, perception of the medical-use and adult-use marijuana industry, bureaucratic delays or inefficiencies or any other reasons; any other factors or developments which may hinder market growth; Rubicon Organics’ limited operating history and lack of historical profits; reliance on management; and the effect of capital market conditions and other factors on capital availability; competition, including from more established or better financed competitors; and the need to secure and maintain corporate alliances and partnerships, including with customers and suppliers. These factors should be considered carefully and readers are cautioned not to place undue reliance on such forward-looking statements. Although Rubicon Organics has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. Rubicon Organics assumes no obligation to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.

2019-03-11T22:44:05-07:00